Screener
Evolent Health, Inc. EVH Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Repayment of debt | (10,000) | (62,500) |
| Payment of preferred dividends | — | (9,198) |
| Taxes withheld and paid for vesting of equity awards | (1,823) | (4,621) |
| Net cash and restricted cash (used in) provided by financing activities | (14,966) | 98,927 |
| Effect of exchange rate on cash and cash equivalents and restricted cash | (863) | (60) |
| Net decrease in cash and cash equivalents and restricted cash | (39,230) | (526) |
| Cash and cash equivalents and restricted cash as of beginning-of-period | 180,696 | 178,496 |
| Cash and cash equivalents and restricted cash as of end-of-period | $141,466 | $177,970 |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s financing cash flow?
- Evolent Health, Inc. (EVH) reported financing cash flow of -$10.99M in Q2 2026.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Evolent Health, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude